Neurospace is a company focused on developing innovative solutions for neurological disorders. They specialize in advanced neurostimulation technologies aimed at improving the quality of life for patients with conditions such as epilepsy. Their flagship product is designed to provide responsive neurostimulation, which helps to reduce the frequency of seizures in individuals who do not respond well to traditional treatments. Neurospace emphasizes a patient-centered approach, leveraging cutting-edge research and technology to enhance therapeutic outcomes.